Comparative Pharmacology
Head-to-head clinical analysis: CLOMIPHENE CITRATE versus OSPEMIFENE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLOMIPHENE CITRATE versus OSPEMIFENE.
CLOMIPHENE CITRATE vs OSPEMIFENE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Selective estrogen receptor modulator; competes with estrogen for binding at estrogen receptors in the hypothalamus, inhibiting negative feedback and increasing gonadotropin-releasing hormone (GnRH) secretion, leading to increased LH and FSH release from the pituitary.
Ospemifene is a selective estrogen receptor modulator (SERM) that acts as an agonist on estrogen receptors in vaginal tissues, leading to proliferation and maturation of vaginal epithelium, while exhibiting antagonist activity on breast and endometrial tissues.
50 mg orally once daily for 5 days, starting on day 5 of menstrual cycle; may increase to 100 mg orally once daily for 5 days if ovulation not achieved.
60 mg orally once daily.
None Documented
None Documented
Clinical Note
moderateOspemifene + Sulfisoxazole
"The serum concentration of Sulfisoxazole can be increased when it is combined with Ospemifene."
Clinical Note
moderateOspemifene + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Ospemifene."
Clinical Note
moderateOspemifene + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Ospemifene."
Clinical Note
moderateOspemifene + Fluconazole
Terminal elimination half-life is approximately 5–7 days (120–168 hours) for the active zu-isomer, with a longer half-life for its metabolites. This prolonged half-life leads to accumulation with repeated dosing and sustained clinical effects.
Terminal elimination half-life is approximately 26 hours (range 20–30 hours), supporting once-daily dosing.
Primarily fecal (approximately 50%), with about 8% renal excretion of unchanged drug and metabolites. Biliary excretion is significant, with enterohepatic recirculation contributing to prolonged elimination.
Primarily hepatic metabolism with biliary excretion; < 30% renal elimination as metabolites. Fecal excretion accounts for approximately 70% of total clearance.
Category A/B
Category C
Selective Estrogen Receptor Modulator (SERM)
Selective Estrogen Receptor Modulator (SERM)
"The serum concentration of Fluconazole can be increased when it is combined with Ospemifene."